 Null Hypothesis It is expected that tirofiban arm will provide over 90 platelet aggregation inhibition compared to the Clopidogrel alone arm which will provide a maximum of 50 platelet aggregation inhibition. Therefore, an expected difference of 40 in platelet inhibition is anticipated in this pilot trial. 